Details

Autor(en) / Beteiligte

• Guo, Boya
• Knerr, Sarah
• Kauffman, Tia L.
• Mittendorf, Kathleen F.
• Keast, Erin
• Gilmore, Marian J.
• Feigelson, Heather Spencer
• Lynch, Frances L.
• Muessig, Kristin R.
• Okuyama, Sonia
• Zepp, Jamilyn M.
• Veenstra, David L.
• Hsu, Li
• Phipps, Amanda I.
• Lindström, Sara
• Leo, Michael C.
• Goddard, Katrina A. B.
• Wilfond, Benjamin S.
• Devine, Beth
• Allen, Jake
• Amendola, Laura M.
• Anderson, Katherine P.
• Angelo, Frank
• Arnold, Briana L.
• Bellcross, Cecelia
• Bendelow, Tiffany
• Biesecker, Barbara B.
• Breslin, Kristin D.
• Bulkley, Joanna E.
• Booker, Kristina F.
• Caruncho, Mikaella
• Davis, James V.
• Deutsch, Sonia
• Dorschner, Michael O.
• Duenas, Devan M.
• Eubanks, Donna J.
• Freed, Amanda S.
• Greaney, Clay
• Gruß, Inga
• Guerra, Claudia
• Holup, Joan
• Hunter, Jessica Ezzell
• Ingphakorn, Chalinya L.
• Jackson, Paige
• Jarvik, Gail P.
• Jenkins, Charisma L.
• Joseph, Galen
• Karliner, Leah S.
• Koomas, Alyssa H.
• Kraft, Stephanie A.
• Lee, Mi H.
• Lee, Robin
• Lee, Sandra Soo‐Jin
• Lewis, Hannah S.
• Liles, Elizabeth G.
• Lindberg, Nangel M.
• McMullen, Carmit K.
• Medina, Elizabeth
• Peterson, C. Samuel
• Paolucci, Angela R.
• Perez, Rosse Rodriguez
• Porter, Kathryn M.
• Ransom, Chelese L.
• Reyes, Ana
• Riddle, Leslie S.
• Robinson, Sperry
• Rolf, Bradley A.
• Rope, Alan F.
• Schield, Emily
• Schneider, Jennifer L.
• Shipman, Kelly J.
• Shirts, Brian H
• Shuster, Elizabeth
• Syngal, Sapna
• Torgrimson‐Ojerio, Britta N.
• Ukaegbu, Chinedu
• Vandermeer, Meredith L.
• Varga, Alexandra M.
• Whitebirch, W. Chris
• White, Larissa Lee

Titel

Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study

Ist Teil von

• Cancer medicine (Malden, MA), 2023-09, Vol.12 (18), p.19112-19125

Ort / Verlag

United States: John Wiley & Sons, Inc

Erscheinungsjahr

2023

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Background Genetic testing can identify cancer risk early, enabling prevention and early detection. We describe use of risk management interventions following genetic testing in the Cancer Health Assessment Reaching Many (CHARM) study. CHARM assessed risk and provided genetic testing to low income, low literacy, and other underserved populations that historically face barriers to accessing cancer genetic services. Methods CHARM was implemented in Kaiser Permanente Northwest (KPNW) and Denver Health (DH) between 2018 and 2020. We identified post‐testing screening (mammography, breast MRI, colonoscopy) and surgical (mastectomy, oophorectomy) procedures using electronic health records. We examined utilization in participants who did and did not receive actionable risk management recommendations from study genetic counselors following national guidelines. Results CHARM participants were followed for an average of 15.4 months (range: 0.4–27.8 months) after results disclosure. Less than 2% (11/680) received actionable risk management recommendations (i.e., could be completed in the initial years following testing) based on their test result. Among those who received actionable recommendations, risk management utilization was moderate (54.5%, 6/11 completed any procedure) and varied by procedure (mammogram: 0/3; MRI: 2/4; colonoscopy: 4/5; mastectomy: 1/5; oophorectomy: 0/3). Cancer screening and surgery procedures were rare in participants without actionable recommendations. Conclusion Though the number of participants who received actionable risk management recommendations was small, our results suggest that implementing CHARM's risk assessment and testing model increased access to evidence‐based genetic services and provided opportunities for patients to engage in recommended preventive care, without encouraging risk management overuse.